2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $62K | $400K | $382K | $550K | $135K |
Cost of Revenue | $13K | $253K | $81K | $28K | $123K |
Gross Profit | $49K | $147K | $301K | $522K | $12K |
Gross Profit % | 79% | 37% | 79% | 95% | 8.9% |
R&D Expenses | $8.4M | $8.8M | $10M | $13M | $11M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$15M | -$16M | -$17M | -$20M | -$18M |
Dep. & Amort. | $179K | $785K | $1.5M | $1.4M | $1.4M |
Def. Tax | $0 | -$4.1M | -$6.3M | $0 | $0 |
Stock Comp. | $3M | $3M | $3.4M | $4M | $3.9M |
Chg. in WC | -$550K | -$485K | $69K | $38K | $128K |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $38M | $29M | $21M | $13M | $26M |
ST Investments | $0 | $0 | $0 | $6.9M | $995K |
Cash & ST Inv. | $38M | $29M | $21M | $20M | $27M |
Receivables | $0 | $0 | $0 | $629K | $79K |
Inventory | $0 | $0 | $0 | $0 | $0 |
Atomera announced a significant partnership with a major capital equipment provider, aimed at accelerating customer adoption and production of its MST technology, particularly in advanced node and gate-all-around applications; the partnership leverages the partner's resources and sales force without altering Atomera's license/royalty business model.
Progress continues with key customers, notably STMicro, where efforts are focused on manufacturability, yield, and throughput for high-volume production; Atomera is also in active discussions with three additional ST product areas, potentially leading to new licenses and royalty streams.
The company is seeing increased customer interest and activity across multiple segments, including RF SOI (with new focus on low noise amplifiers for 5G), power electronics (driven by AI server demand), and memory (with new patents in DRAM sense amplifiers).
Atomera completed the world's first GaN devices using MST technology in partnership with Sandia National Labs, showing early indications of improved electrical performance; further optimization and data collection are underway to target the fast-growing GaN market.
Financially, Q1 2025 GAAP net loss was $5.0M ($0.17/share) with non-GAAP net loss at $4.4M; cash and equivalents were $24.1M as of March 31, 2025; full-year 2025 non-GAAP OpEx is expected to be $17.25M–$17.75M; Q2 revenue is projected between $0–$50,000, with major revenue milestones tied to STMicro process qualification.